Biocon | Page 3 | Business Upturn

Latest Articles

Biocon Pharma secures US FDA approvals for Lenalidomide, Dasatinib, and Rivaroxaban tablets

Corporates · Mar 4, 2025

By Aditya Bhagchandani

blank

Biocon launches Liraglutide for diabetes and obesity in the UK

Corporates · Feb 28, 2025

blank

Biocon shares surge 2.2% after its subsidiary launches YESINTEK™ in the US

Stock Market · Feb 25, 2025

blank

Biocon Biologics launches YESINTEK™ in the United States

Corporates · Feb 24, 2025

blank

Biocon shares up nearly 3% as Q3 results highlight EBITDA growth of 16% and revenue rise of 7%

Stock Market · Jan 31, 2025

By Aditya Bhagchandani

blank

Top Q3 FY25 Results Today on January 30, 2025: Adani Enterprises, Adani Ports, Bajaj Finserv, BEL, Biocon, Dabur, Prestige Estates

Corporates · Jan 30, 2025

By Aditya Bhagchandani

blank

Biocon shares surge nearly 4% as HSBC upgrades to ‘Buy’

Stock Market · Jan 14, 2025

By Aditya Bhagchandani

blank

Biocon shares surge 4% today; Motilal Oswal upgrades stock to Buy

Stock Market · Jan 13, 2025

By Aditya Bhagchandani

blank

Biocon shares jump 3% as U.S. FDA classifies Johor Bahru facility as VAI

Stock Market · Jan 13, 2025

blank

Top stocks to watch in trade today: DMart, PCBL, Biocon, Just Dial, Waaree Energies and more

Stock Market · Jan 13, 2025

blank

Biocon Update: U.S. FDA classifies Johor Bahru facility as VAI

Corporates · Jan 12, 2025

By Aditya Bhagchandani

blank

Biocon shares rise 3% as subsidiary secures Japanese PMDA approval for Ustekinumab biosimilar

Stock Market · Jan 7, 2025

By Aditya Bhagchandani

blank

Biocon Biologics secures PMDA approval for Ustekinumab biosimilar in Japan

Corporates · Jan 7, 2025

By Aditya Bhagchandani

blank

Biocon gets VAI status from US FDA for Bengaluru API facility

Corporates · Dec 24, 2024

blank

Biocon shares jump 2% on EU approval for Liraglutide formulation

Stock Market · Dec 24, 2024

Showing 45 of 70 articles